The prognostic impact of neoadjuvant chemoradiotherapy on lymph node sampling in patients with locally advanced rectal cancer

[1]  D. Dai,et al.  Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer , 2019, Front. Oncol..

[2]  M. Barchitta,et al.  Predictive Value of the Number of Harvested Lymph Nodes and Cut-Off for Lymph Node Ratio in the Prognosis of Stage II and III Colorectal Cancer Patients , 2019, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[3]  A. Biondi,et al.  The Prognostic Impact of the Metastatic Lymph Nodes Ratio in Colorectal Cancer , 2018, Front. Oncol..

[4]  P. McMurrick,et al.  Role of lymph node yield and lymph node ratio in predicting outcomes in non‐metastatic colorectal cancer , 2018, BJS open.

[5]  M. Morino,et al.  Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the "Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network" (SICO-CCN) multicentre collaborative study. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  Wan-bin He,et al.  Lymph node ratio is an independent prognostic factor for rectal cancer after neoadjuvant therapy: A meta‐analysis , 2018, Journal of evidence-based medicine.

[7]  E. Aly,et al.  ‘Watch and wait’ in rectal cancer: summary of the current evidence , 2018, International Journal of Colorectal Disease.

[8]  G. Qin,et al.  A statistical tool for risk assessment as a function of the number of lymph nodes retrieved from rectal cancer patients , 2018, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[9]  A. Liverani,et al.  The impact of log odds of positive lymph nodes (LODDS) in colon and rectal cancer patient stratification: a single-center analysis of 323 patients , 2018, Updates in Surgery.

[10]  Sanghyun Cho,et al.  Patterns of Rectal Cancer Radiotherapy Adopting Evidence-Based Medicine: An Analysis of the National Database from 2005 to 2016 , 2017, Cancer research and treatment : official journal of Korean Cancer Association.

[11]  I. Cecconello,et al.  Understanding the factors associated with reduction in the number of lymph nodes in rectal cancer patients treated by neoadjuvant treatment , 2017, International Journal of Colorectal Disease.

[12]  D. Berger,et al.  The Impact of Pathologic Complete Response in Patients with Neoadjuvantly Treated Locally Advanced Rectal Cancer—a Large Single-Center Experience , 2017, Journal of Gastrointestinal Surgery.

[13]  T. Schuster,et al.  Lymph node yield after rectal resection in patients treated with neoadjuvant radiation for rectal cancer: A systematic review and meta-analysis. , 2017, European journal of cancer.

[14]  A. Benson,et al.  Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[15]  A. Passardi,et al.  Why is neoadjuvant chemoradiation therapy underused for locally advanced rectal cancer? , 2016, Expert review of gastroenterology & hepatology.

[16]  J. Coffey,et al.  Neoadjuvant therapy does not affect lymph node ratio in rectal cancer. , 2016, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[17]  K. Dev,et al.  Less than 12 lymph nodes in the surgical specimen after neoadjuvant chemo-radiotherapy: an indicator of tumor regression in locally advanced rectal cancer? , 2016, Journal of gastrointestinal oncology.

[18]  Y. He,et al.  Effect of neoadjuvant radiotherapy on lymph node ratio of rectal cancer patients: An ordinal logistic regression analysis. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  E. Goetghebeur,et al.  Effect of Neoadjuvant Radiation Dose and Schedule on Nodal Count and Its Prognostic Impact in Stage II–III Rectal Cancer , 2016, Annals of Surgical Oncology.

[20]  O. Hallböök,et al.  Nodal involvement in luminal complete response after neoadjuvant treatment for rectal cancer. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  D. Hemingway,et al.  Complete radiotherapy response in rectal cancer: A review of the evidence. , 2016, World journal of gastroenterology.

[22]  Seung-Yong Jeong,et al.  Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy , 2015, PloS one.

[23]  P. Hermanek,et al.  Lymphknotendissektion nach primärer Chirurgie und neoadjuvanter Radiochemotherapie des Rektumkarzinoms , 2015, Der Chirurg.

[24]  O. Zmora,et al.  Regional lymph node status after neoadjuvant chemoradiation of rectal cancer producing a complete or near complete rectal wall response , 2015, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[25]  David D. Smith,et al.  Impact of Total Lymph Node Count on Staging and Survival After Neoadjuvant Chemoradiation Therapy for Rectal Cancer , 2015, Annals of Surgical Oncology.

[26]  Jong Hoon Kim,et al.  Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy. , 2015, World journal of gastroenterology.

[27]  I. Di Carlo,et al.  Colorectal cancer and lymph nodes: the obsession with the number 12. , 2014, World journal of gastroenterology.

[28]  A. Di Cataldo,et al.  Rare hepatic metastases of colorectal cancer in livers with symptomatic HBV and HCV hepatitis. , 2013, Annali italiani di chirurgia.

[29]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[30]  E. Weiss,et al.  The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[31]  W. Hohenberger,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[32]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[33]  A. Jamshed,et al.  Impact of lymph node ratio and number on survival in patients with rectal adenocarcinoma after preoperative chemo radiation. , 2015, International journal of surgery.

[34]  E. Glatstein.  Preoperative Versus Postoperative Chemoradiotherapy for Rectal Cancer , 2006 .

[35]  O. Dworak,et al.  Pathological features of rectal cancer after preoperative radiochemotherapy , 1997, International Journal of Colorectal Disease.